Revenue and Profit - Revenue for Q3 2022 reached ¥252,459,768.99, an increase of 66.06% year-over-year[4] - Net profit attributable to shareholders was ¥58,684,970.20, a significant increase of 420.25% compared to the same period last year[4] - The net profit excluding non-recurring gains and losses was ¥60,482,619.71, up 504.64% year-over-year[4] - Basic earnings per share for Q3 2022 was ¥0.54, reflecting a 285.71% increase from the previous year[4] - Revenue for the first nine months of 2022 reached CNY 774.80 million, a 31.55% increase compared to CNY 588.99 million in the same period of 2021[8] - Net profit for the first nine months of 2022 was CNY 146.99 million, representing a 97.09% increase from CNY 74.58 million in the same period of 2021[8] - The total profit for the first nine months of 2022 was CNY 171.32 million, a 102.11% increase compared to CNY 84.76 million in the same period of 2021[8] - The total profit for Q3 2022 was CNY 171,319,787.39, compared to CNY 84,764,259.86 in Q3 2021, representing a year-over-year increase of 102.3%[17] - The net profit attributable to shareholders of the parent company reached CNY 142,515,984.86, up from CNY 70,322,076.90 in the same period last year, marking a growth of 102.4%[17] Assets and Equity - Total assets as of September 30, 2022, amounted to ¥1,681,078,746.85, representing a 91.75% increase from the end of the previous year[4] - Shareholders' equity attributable to the company reached ¥1,272,832,360.98, a 199.08% increase compared to the previous year-end[4] - The company’s total assets increased by 426.92% in other non-current assets, reaching CNY 38.21 million, due to increased prepayments for projects and equipment[8] - Total assets as of September 30, 2022, were CNY 1,681,078,746.85, compared to CNY 876,682,063.24 at the beginning of the year, reflecting a growth of 91.5%[14] - Current assets totaled CNY 1,243,250,100.81, significantly up from CNY 472,459,926.95 at the start of the year, marking a 163.0% increase[13] - The company’s equity attributable to shareholders rose to CNY 1,272,832,360.98, up from CNY 425,575,774.53, an increase of 199.5%[15] Cash Flow and Financing - Cash flow from operating activities for the year-to-date was ¥15,863,771.42, showing a decline of 89.75%[4] - Cash and cash equivalents increased by 444.04% to ¥785,666,926.39, mainly due to funds raised from a public stock offering[7] - Cash flow from operating activities decreased by 89.75% to CNY 15.86 million, mainly due to an increase in accounts receivable[8] - Operating cash inflow totaled CNY 712,493,396.88, an increase from CNY 612,829,685.11 in the previous year, indicating a growth of 16.3%[19] - The net cash flow from operating activities was CNY 15,863,771.42, down from CNY 154,797,601.88 in the same quarter last year, showing a decline of 89.7%[19] - The company raised CNY 749,048,962.26 from investment activities, a significant increase compared to the previous year[19] - The net cash flow from financing activities was CNY 661,422,287.18, compared to a negative cash flow of CNY -53,689,501.44 in the same period last year[19] Costs and Expenses - Total operating costs amounted to CNY 602,229,041.28, up 19.4% from CNY 504,484,775.34 in the prior period[16] - Research and development expenses for the period were CNY 23,253,115.75, compared to CNY 20,533,558.99 in the previous period, indicating a 8.3% increase[16] Non-Recurring Items - The company reported a non-recurring loss of ¥1,797,649.51 for Q3 2022, primarily due to foreign exchange derivative investment losses[5] - The company reported a significant increase in investment income, rising 578.07% to CNY 1.68 million, attributed to gains from derivative financial instruments[8] Other Information - The company did not undergo an audit for the Q3 2022 report[20]
联盛化学(301212) - 2022 Q3 - 季度财报